Disease Area Offered: Model Development

Reaching the Tumor: Mobility of Polymeric Micelles Inside an In Vitro Tumor-on-a-Chip Model with Dual ECM

Microphysiological Endothelial Models to Characterize Subcutaneous Drug Absorption

Microfluidic model of the alternative vasculature in neuroblastoma

Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip

The OrganiX microfluidic system to recreate the complex tumour microenvironment

YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer

Affinity fine-tuning anti-CAIX CAR-T cells mitigate on target off-tumor side effects

CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment

ID1high/activin Ahigh glioblastoma cells contribute to resistance to anti-angiogenesis therapy through malformed vasculature